F695 in Delaware. Pick another state for the same tag.
Against expectation — 2025
Delaware cites F695 more often than its own record predicts
Versus expected share1.25×
1.25 times the share F695 takes of citations nationally.
Share of Delaware citations2.77%
Of every deficiency written in Delaware in 2025, this is the portion that was F695.
Delaware2.77%
National2.20%
Share of all citations that were F695.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F695 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
J · Immediate jeopardy, isolatedAugust 10, 2023
Based on observation, interview and record review, it was determined that for one out of one resident (R49) reviewed for respiratory/tracheostomy care, the facility failed to provide tracheal suctioning consistent with professional standards of practice. Findings included:
The following was reviewed in R49's clinical record:
9/18/22 - R49 was admitted to the facility from an acute hospital with a diagnosis of respiratory failure.
10/29/20 - Per physician's order, trach care daily and as needed: for disposable: remove and dispose inner cannula. Replace with new inner cannula as needed for reduce risk of infection.
2/21/22 - Per physician's order, suction every shift and as needed for maintain patent airway. …
D · No harm, potential for more than minimal, isolatedAugust 17, 2026
Based on observation, interview, and record review, it was determined that for two (R16 and R27) out of two residents reviewed for respiratory care, the facility failed to ensure the respiratory equipment was stored in plastic bagging when not in use. Findings include:
1. R16 was admitted to the facility with the following diagnoses, including but not limited to, pneumonia, shortness of breath, and chronic obstructive pulmonary disease.
7/23/26 – A review of R16's physician's orders documented Ipratropium-Albuterol Solution 0.5-2.5 (3) mg/3 mL, to be inhaled orally every eight hours as needed for wheezing/shortness of breath for 14 days, and 3 mL to be inhaled orally three times a day for shortness of breath/wheezing. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction